Helpful Links and Downloads

As you’re going through treatment, you may face new challenges physically and emotionally. It’s important to remember you’re not alone. In this section, you’ll find resources to help you in the journey ahead.

Photo of man wearing a backpack standing atop mountain
Discussion Guide Icon+

Click on the icon to select topics that interest you. Topics you select will be added to your discussion guide on the right.

Downloads

Find helpful information in these downloadable PDFs.

Nutrition Guide

The hows and whys of nutrition for people on lung cancer therapy

Download nutrition guide

Exercise Guide

The importance of exercise during lung cancer treatment and exercise tips and techniques

Download exercise guide

FAQs

Answers to frequently asked questions

Download FAQs

Download free ALIMTA therapy guides

Information about initial therapy and maintenance therapy with ALIMTA

Support Programs

You are not alone on your journey. Cancer support groups let you share your experience and learn how others cope. Your doctor, nurse, or social worker may know about support groups in your area. Some support groups also meet through the Internet.

Advocacy groups

Advocacy groups educate, inform, fund research, and more. Many advocacy groups can also help you find local resources and cancer support groups.

Lung Cancer–Specific Organizations

American Lung Association

www.lung.org

The American Lung Association has been fighting for over 100 years to save lives by improving lung health and preventing lung disease through education, advocacy, and research. This organization offers several support groups, including the Lung Connection Community. This free online community is for people who are living with lung diseases and their caregivers.

Bonnie J. Addario Lung Cancer Foundation

www.lungcancerfoundation.org

The Bonnie J. Addario Lung Cancer Foundation (ALCF) is a nonprofit organization that actively works with physicians, organizations, and people affected by lung cancer. Its goal is to identify solutions and make progress toward turning lung cancer into a chronically managed disease. To date, this philanthropy (patient-founded, patient-focused, and patient-driven) has raised almost $25 million for lung cancer research and programs.

Lung Cancer Alliance

www.lungcanceralliance.org

Lung Cancer Alliance is a nonprofit organization solely dedicated to saving lives and advancing research by empowering those living with and at risk for lung cancer. It offers personalized, professional support, advocate for increased lung cancer research funding, and conducts nationwide education campaigns.

LUNGevity Foundation

www.lungevity.org

LUNGevity is focused on changing outcomes for people living with lung cancer through research, education, and support. LUNGevity strategically funds a robust portfolio of translational research to find lung cancer early and treat it more effectively. The organization also provides a community of empowerment, support, and hope for everyone affected by lung cancer through its extensive educational resources, online peer-to-peer support, and in-person survivorship programs.

General Cancer Resources

American Cancer Society

www.cancer.org

The American Cancer Society (ACS) has worked to save lives and fight cancer for over 100 years. This organization provides programs and services to support people with cancer and their caregivers through treatment and recovery.

CancerCare

cancercare.org

Founded in 1944, CancerCare is a national organization providing free, professional support services and information to help people manage the emotional, practical, and financial challenges of cancer. Its comprehensive services include counseling and support groups over the phone, online, and in person; educational workshops; publications; and financial and co-payment assistance. All CancerCare services are provided by oncology social workers and world-leading cancer experts. CancerCare founded Lungcancer.org in 1998 as a source of support and information for lung cancer patients and their loved ones.

All third-party names, brands, and other trademarks are the property of their respective trademark owners. Those trademark owners are not affiliated with Lilly and they do not sponsor or endorse this material.

Additional Resources

Care beyond treatment

Treating the physical side of cancer is just the start. Emotions are important too. Lilly Oncology strives to offer resources to help ease the difficult times and celebrate the good ones.

Find resources
Indications and Important Safety Information

What Is ALIMTA® (pemetrexed for injection) Approved For?

ALIMTA® (pemetrexed for injection) is approved by the FDA in combination with cisplatin (another chemotherapy drug) for the first (initial) treatment of advanced nonsquamous non-small cell lung cancer (NSCLC), a specific type of NSCLC that has spread.

ALIMTA is approved by the FDA as a single agent (used alone) for maintenance treatment of patients with advanced nonsquamous non-small cell lung cancer (NSCLC) after you have received 4 cycles of chemotherapy that contains platinum for first treatment and your cancer has not progressed.

ALIMTA is approved by the FDA as a single agent (used alone) for the treatment of patients with recurrent, metastatic nonsquamous non-small cell lung cancer (NSCLC), a specific type of NSCLC, which has returned or spread after prior chemotherapy.

ALIMTA is not appropriate for people who have a different type of NSCLC called squamous cell.

Important Safety Information for ALIMTA

What is the most important information that I should know about ALIMTA?

ALIMTA can cause serious side effects including:

  • Low blood cell counts. Low blood cell counts can be severe, including low white blood cell counts (neutropenia), low platelet counts (thrombocytopenia), and low red blood cell counts (anemia). Your healthcare provider will do blood test to check your blood cell counts regularly during your treatment with ALIMTA. Tell your healthcare provider right away if you have any signs of infection, fever, bleeding, or severe tiredness during your treatment with ALIMTA.
  • Kidney problems, including kidney failure. ALIMTA can cause severe kidney problems that can lead to death. Severe vomiting or diarrhea can lead to loss of fluids (dehydration) which may cause kidney problems to become worse. Tell your healthcare provider right away if you have a decrease in amount of urine.
  • Severe skin reactions. Severe skin reactions that may lead to death can happen with ALIMTA. Tell your healthcare provider right away if you develop blisters, skin sores, skin peeling, or painful sores, or ulcers in your mouth, nose, throat or genital area.
  • Lung problems (pneumonitis). ALIMTA can cause serious lung problems that can lead to death. Tell your healthcare provider right away if you get any new or worsening symptoms of shortness of breath, cough, or fever.
  • Radiation recall. Radiation recall is a skin reaction that can happen in people who have received radiation treatment in the past and are treated with ALIMTA. Tell your healthcare provider if you get swelling, blistering, or a rash that looks like a sunburn in an area that was previously treated with radiation.

Who should not take ALIMTA?

ALIMTA may not be appropriate for some patients. If you are allergic to pemetrexed, tell your doctor because you should not receive it. It is not known if ALIMTA is safe and effective in children.

What should I tell my healthcare provider before receiving ALIMTA?

  • Before receiving ALIMTA, tell your healthcare provider about all of your medical conditions including:
    • if you have kidney problems.
    • if you have had radiation therapy.
    • if you think you are pregnant, or are planning to become pregnant as ALIMTA can harm your unborn baby.
      • Females who are able to become pregnant should use effective birth control (contraception) during treatment with ALIMTA and for 6 months after the final dose. Tell your healthcare provider right away if you become pregnant or think you are pregnant during treatment with ALIMTA.
      • Males with female partners who are able to become pregnant should use effective birth control (contraception) during treatment with ALIMTA and for 3 months after the final dose.
    • if you are breastfeeding or plan to breastfeed, as it is not known if ALIMTA passes into breast milk. Do not breastfeed during treatment with ALIMTA and for 1 week after the final dose.
  • Tell your healthcare provider about all of the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
  • Tell your healthcare provider if you have kidney problems and take a medicine that contains ibuprofen. You should avoid taking ibuprofen for 2 days before, the day of, and 2 days after receiving treatment with ALIMTA.

How is ALIMTA given?

  • It is very important to take folic acid by mouth and receive vitamin B12 injections from your healthcare provider during your treatment with ALIMTA to lower your risk of harmful side effects.
  • Your healthcare provider will prescribe a medicine called a corticosteroid for you to take 2 times a day for 3 days, beginning the day before each treatment with ALIMTA.
  • ALIMTA is given to you by intravenous (IV) infusion (injection) into your vein. The infusion is given over 10 minutes. You will usually receive ALIMTA once every 21 days (3 weeks).

What are the possible side effects of ALIMTA?

The most common side effects of ALIMTA when given alone are:

  • Tiredness
  • Nausea
  • Loss of appetite

The most common side effects of ALIMTA when given with cisplatin are:

  • Vomiting
  • Swelling or sores in your mouth or sore throat
  • Constipation
  • Low white blood cell counts (neutropenia)
  • Low platelet counts (thrombocytopenia)
  • Low red blood cell counts (anemia)

ALIMTA may cause fertility problems in males. This may affect your ability to father a child. It is not known if these effects are reversible. Talk to your healthcare provider if this is a concern for you.

Your healthcare provider will do blood tests to check for side effects during treatment with ALIMTA. Your healthcare provider may change your dose of ALIMTA, delay treatment, or stop treatment if you have certain side effects. Tell your healthcare provider if you have any side effect that bothers you or that does not go away.

These are not all the side effects of ALIMTA. For more information, ask your healthcare provider or pharmacist. Call your doctor for medical advice about side effects.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

ALIMTA is available by prescription only.

For more information about all of the side effects of ALIMTA, please talk with your healthcare team, see the Patient Prescribing Information and full Prescribing Information, or call 1-800-545-5979.

PM_CON_ISI_All_16OCT2017